bromodeoxyuridine has been researched along with Atrophy, Muscular, Peroneal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Antonio, M; Del Carro, U; Feltri, ML; Malaguti, M; Pennuto, M; Quattrini, A; Ron, D; Tinelli, E; Wrabetz, L | 1 |
1 other study(ies) available for bromodeoxyuridine and Atrophy, Muscular, Peroneal
Article | Year |
---|---|
Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice.
Topics: Age Factors; Animals; Animals, Newborn; Bromodeoxyuridine; Charcot-Marie-Tooth Disease; CHO Cells; Cricetinae; Cricetulus; Demyelinating Diseases; Disease Models, Animal; Endoplasmic Reticulum; Gene Expression Regulation; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Motor Activity; Mutation; Myelin P0 Protein; Nerve Fibers, Myelinated; Signal Transduction; Transcription Factor CHOP; Transfection | 2008 |